Health
German court suspends mRNA patent proceedings against BioNTech
A German court on Thursday suspended patent proceedings against BioNTech over the use of mRNA technology in a COVID-19 vaccine developed by the German company
Gritstone wins $433 million contract to research a vaccine against COVID
The US government has awarded Gritstone Biography a $433 million contract to conduct an interim study of a self-amplifying mRNA vaccine candidate against COVID-19. The
McKinsey to pay $230 million in compensation for opioids in the US
Consulting firm McKinsey & Co has agreed to pay $230 million to settle lawsuits by hundreds of local governments and school districts in the US
The UK’s first supervised drug injection site has been approved
The UK’s first formal controlled drug consumption room was approved on Wednesday to reduce infectious diseases and overdoses in Scotland, which suffers the highest rate
Cough syrup deaths have led to tougher toxicity testing measures in the US
The US FDA is cracking down on lax testing practices by dozens of health product makers after hundreds of deaths overseas from contaminated cough syrups,
Japan has approved Eisai and Biogen’s Leqembi treatment for Alzheimer’s disease
Japanese company Eisai has announced that its Alzheimer’s disease treatment developed with Biogen, Leqembi, has been approved by the country’s Ministry of Health, making it
Novartis confirms the spin-off of Sandoz on 4 October 2023
Novartis on Monday confirmed its plans for a 100% spin-off of its Sandoz business on 4 October after shareholders gave their approval earlier this month.
Novo Nordisk and Valo to research cardiometabolic treatments
Danish drugmaker Novo Nordisk announced it will collaborate with US technology company Valo Health to discover and develop new treatments for cardiometabolic diseases using human
U.S. FDA finds violations at Novo’s main U.S. plant in May 2022
Back in May last year, U.S. drug regulators published a report detailing quality control violations at Novo Nordisk’s main North American plant, according to a
The US government has allocated $45 million for long-term COVID clinics
The U.S. government is awarding $45 million in grants to help clinics treating protracted COVID develop new models of care and expand access, the Department